Author:
Nagai Goyo,Mihara Kazuo,Nakamura Akifumi,Nemoto Kenji,Kagawa Shoko,Suzuki Takeshi,Kondo Tsuyoshi
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference22 articles.
1. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology;Shapiro;Neuropsychopharmacology,2003
2. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder;Harrison;Drugs,2004
3. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenia Trial of Aripiprazole (STAR) study;Kerwin;Eur Psychiatry.,2007
4. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptors and cytochrome P450 2D6 in Japanese patients with schizophrenia;Nagai;Psychiatry Clin Neurosci.,2012
5. Improvement in antipsychotic-induced hyperprolactinemia with addition of aripiprazole in schizophrenic patients;Mihara;Clin Neuropsychopharmacol Ther.,2011
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献